Navigation Links
Model 785 Vacuum Blotter System 120 V

ProductsModel 785 Vacuum Blotter System 120 V
Company Bio-Rad Lab Equipment
Item Model 785 Vacuum Blotter System 120 V
Features Inquire
Description Includes vacuum pump, vacuum regulator, base with vacuum stage, porous vacuum plate, reservoir seal O-ring, sealing frame, assorted window gaskets, lid, instructions. The Model 785 vacuum blotter quickly and efficiently transfers DNA or RNA from an agarose gel onto a nylon membrane. Because it generally requires only 90 min for transfer, the nucleic acid samples can be separated on a gel, transferred to a membrane, and the hybridization reaction begun on the same day.
Info Bio-Rad Lab Equipment
Customer Service: 510-741-5790
Web site: http://www.bio-rad.com/

Related medicine products :

1. Reliance Stool, Model 5346
2. Reliance Stools, Model 5340
3. Reliance Stool, Model 5356
4. Reliance Stool, Model 5348
5. Pachymetric Analyzer Model 55
6. Model 1990 Dermatome
7. The New Model C Dermatome
8. NEW Padgett Model PI - Electro-Dermatome
9. Amo Phaco Model Diplomax
10. KR 4.22 Programmable Refrigerated Floor Model Centrifuge.
11. Model 420 UV Visible Spectrophotometer
A straight suture punch with 2.5 mm needle and 2/0 to #1 monofilament suture.
...provide superior tissue excision with precision-ma...pers offer an aggressive tooth pattern to capture ...nique stress pin buffering system to minimize tip ...ffering system applies increasing tension to the i...
Athroscopic leg holder system.
...er-pumps, the REVOLUTION provides continuous flow,...ermore the dual pump system gives the surgeon tota...ate. , ,The REVOLUTION system includes foot pedal ...y to increase flow while maintaining joint pressur...
Medicine Products:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
... must get its act together to check the perilous t... to the department has suggested a cap on the// em...rt panel set in motion by the Human Fertilization ...ggested that the number of embryos implanted in th...
... proved to be efficient on animals according to re... "Perhaps we can cure HIV infection. This is our ...stern Ontario. Clinical trials of the vaccine are ...to be invested by Curocom Co., a company in Korea...
... cutting down the risk of Alzheimer's disease by r...s said in a recent communiqué. The finding// hold... marijuana in the 1960s and 1970s are at a lesser ...se, as compared to others of their age. Investiga...
... have divulged that AIDS is no more restricted to ...IDS cases are added each day according to statisti...re doubted to be AIDS positive. It is alarming to ...argest number of AIDS/HIV infections where the mod...
Other Medicine News:
(Date:10/7/2008)...T, Mich., Oct. 7 /- McLaren Health Ca...ing some of the world,s leading medical,minds to s...breast and,gastrointestinal cancer treatments. The...I, was organized by McLaren,s Sukamal Saha, M.D., ... sentinel node mapping for,colorectal cancer has g...
(Date:10/7/2008)...OUVER, Oct. 7 / Burcon Nutr...hat its Puratein(R) and,Supertein(TM) canola prote...) for their intended use in a variety of food and ...-affirmed GRAS through an,independent evaluation b...od safety, toxicology, nutritional sciences, food ...
(Date:10/7/2008)... COLLINS, Colo., Oct. 7 /- A study pu... embryonic stem cell self-renewal,reported that I...ecombinant,human serum albumin) was an effective r...ure., The article entitled, "The ground state of ...researchers used Cellastim as a recombinant,albumi...
(Date:10/7/2008)...ral abstracts highlighting CIMZIA,s long-term bene...se patients presented at American College,of Gastr...re-FirstCall/ -- Data from two studies,presented t...nterology,(ACG) Annual Meeting demonstrate that CI...anti-TNF alpha (Tumor Necrosis Factor alpha) - pro...
Breaking Medicine Technology:News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9School vending machines dole out excess calories fat 27023 1School vending machines dole out excess calories fat 27023 2Childrens asthma affected by parental expectations 27018 1Childrens asthma affected by parental expectations 27018 2Mental barriers hamper obese womens efforts to get exercise 27017 1Mental barriers hamper obese womens efforts to get exercise 27017 2Landmark COPD Trial UPLIFT 28R 29 Shows SPIRIVA 28R 29 HandiHaler 28R 29 Sustained Lung Function Improvements Over Four Years 3208 1Landmark COPD Trial UPLIFT 28R 29 Shows SPIRIVA 28R 29 HandiHaler 28R 29 Sustained Lung Function Improvements Over Four Years 3208 2Landmark COPD Trial UPLIFT 28R 29 Shows SPIRIVA 28R 29 HandiHaler 28R 29 Sustained Lung Function Improvements Over Four Years 3208 3Landmark COPD Trial UPLIFT 28R 29 Shows SPIRIVA 28R 29 HandiHaler 28R 29 Sustained Lung Function Improvements Over Four Years 3208 4Landmark COPD Trial UPLIFT 28R 29 Shows SPIRIVA 28R 29 HandiHaler 28R 29 Sustained Lung Function Improvements Over Four Years 3208 5Landmark COPD Trial UPLIFT 28R 29 Shows SPIRIVA 28R 29 HandiHaler 28R 29 Sustained Lung Function Improvements Over Four Years 3208 6
...rld,s First Commercial Vaccine,for Travellers, Dia...tes Phase I Clinical Trials , ,Trial confirms good..., Denmark, March 28, 2007 -ACE BioSciences A/S, th...ce the successful,completion of Phase I clinical t...irst commercial vaccine for Travellers,Diarrhoea ...
...ey Lung Compartments, REINACH and BASEL, Switzerla...a Ltd. today announced promising,results of "first...Human Microdose studies included a total of 19 hea...is the first ever using Microdosing,for the determ...s.,The results showed that AR-709 achieves high co...
Other Medicine Technology:Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 2Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 3Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 2Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 5